These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1829531

  • 1. Intravenous vs intraperitoneal sensitizer: implications for intraperitoneal photodynamic therapy.
    Perry RR, Smith PD, Evans S, Pass HI.
    Photochem Photobiol; 1991 Mar; 53(3):335-40. PubMed ID: 1829531
    [Abstract] [Full Text] [Related]

  • 2. Photodynamic therapy of the canine peritoneum: normal tissue response to intraperitoneal and intravenous photofrin followed by 630 nm light.
    Tochner Z, Mitchell JB, Hoekstra HJ, Smith P, DeLuca AM, Barnes M, Harrington F, Manyak M, Russo D, Russo A.
    Lasers Surg Med; 1991 Mar; 11(2):158-64. PubMed ID: 1827854
    [Abstract] [Full Text] [Related]

  • 3. Photodynamic therapy of oncogene-transformed cells.
    Pass HI, Evans S, Matthews WA, Perry R, Venzon D, Roth JA, Smith P.
    J Thorac Cardiovasc Surg; 1991 May; 101(5):795-9. PubMed ID: 1827169
    [Abstract] [Full Text] [Related]

  • 4. Photodynamic therapy of 9L gliosarcoma with liposome-delivered photofrin.
    Jiang F, Lilge L, Logie B, Li Y, Chopp M.
    Photochem Photobiol; 1997 Apr; 65(4):701-6. PubMed ID: 9114747
    [Abstract] [Full Text] [Related]

  • 5. Sensitizer for photodynamic therapy of cancer: a comparison of the tissue distribution of Photofrin II and aluminum phthalocyanine tetrasulfonate in nude mice bearing a human malignant tumor.
    Peng Q, Moan J, Kongshaug M, Evensen JF, Anholt H, Rimington C.
    Int J Cancer; 1991 May 10; 48(2):258-64. PubMed ID: 1826901
    [Abstract] [Full Text] [Related]

  • 6. Photodynamic therapy for human malignant mesothelioma in the nude mouse.
    Feins RH, Hilf R, Ross H, Gibson SL.
    J Surg Res; 1990 Oct 10; 49(4):311-4. PubMed ID: 2145473
    [Abstract] [Full Text] [Related]

  • 7. Sensitivity of different human lung cancer histologies to photodynamic therapy.
    Perry RR, Matthews W, Mitchell JB, Russo A, Evans S, Pass HI.
    Cancer Res; 1990 Jul 15; 50(14):4272-6. PubMed ID: 2142015
    [Abstract] [Full Text] [Related]

  • 8. [Selective hematoporphyrin derivative (HMD) application in arterial vessels using a porous balloon catheter results in equivalent levels as compared to high-dose systemic administration].
    Gonschior P, Erdemci A, Gerheuser F, Gonschior GM, Mack B, Kolbe T, Goetz AE, Höfling B.
    Z Kardiol; 1991 Dec 15; 80(12):738-45. PubMed ID: 1837968
    [Abstract] [Full Text] [Related]

  • 9. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.
    Engbrecht BW, Menon C, Kachur AV, Hahn SM, Fraker DL.
    Cancer Res; 1999 Sep 01; 59(17):4334-42. PubMed ID: 10485481
    [Abstract] [Full Text] [Related]

  • 10. Isolation and initial characterization of mouse tumor cells resistant to porphyrin-mediated photodynamic therapy.
    Luna MC, Gomer CJ.
    Cancer Res; 1991 Aug 15; 51(16):4243-9. PubMed ID: 1831066
    [Abstract] [Full Text] [Related]

  • 11. Study of the in vivo and in vitro photosensitizing capabilities of uroporphyrin I compared to photofrin II.
    Nelson JS, Sun CH, Berns MW.
    Lasers Surg Med; 1986 Aug 15; 6(2):131-6. PubMed ID: 2941630
    [Abstract] [Full Text] [Related]

  • 12. Photodynamic therapy efficacy and tissue distribution of hypericin in a mouse P388 lymphoma tumor model.
    Chen B, de Witte PA.
    Cancer Lett; 2000 Mar 13; 150(1):111-7. PubMed ID: 10755394
    [Abstract] [Full Text] [Related]

  • 13. Chronic metabolic measurements of normal brain tissue response to photodynamic therapy.
    Chopp M, Chen Q, Dereski MO, Hetzel FW.
    Photochem Photobiol; 1990 Nov 13; 52(5):1033-6. PubMed ID: 2149611
    [Abstract] [Full Text] [Related]

  • 14. Use of multiple photosensitizers and wavelengths during photodynamic therapy: a new approach to enhance tumor eradication.
    Nelson JS, Liaw LH, Lahlum RA, Cooper PL, Berns MW.
    J Natl Cancer Inst; 1990 May 16; 82(10):868-73. PubMed ID: 2139704
    [Abstract] [Full Text] [Related]

  • 15. A comparison of serum kinetics and tissue distribution of photofrin II following intravenous and intraperitoneal injection in the mouse.
    Pantelides ML, Moore JV, Blacklock NJ.
    Photochem Photobiol; 1989 Jan 16; 49(1):67-70. PubMed ID: 2524073
    [No Abstract] [Full Text] [Related]

  • 16. Photodynamic therapy of human malignant melanoma xenografts in athymic nude mice.
    Nelson JS, McCullough JL, Berns MW.
    J Natl Cancer Inst; 1988 Mar 02; 80(1):56-60. PubMed ID: 2963136
    [Abstract] [Full Text] [Related]

  • 17. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q, Warloe T, Moan J, Godal A, Apricena F, Giercksky KE, Nesland JM.
    Cancer Res; 2001 Aug 01; 61(15):5824-32. PubMed ID: 11479222
    [Abstract] [Full Text] [Related]

  • 18. Protection of murine foot tissue and transplantable tumor against Photofrin-II-mediated photodynamic sensitization with WR-2721.
    Bellnier DA, Dougherty TJ.
    J Photochem Photobiol B; 1989 Nov 01; 4(2):219-25. PubMed ID: 2556509
    [Abstract] [Full Text] [Related]

  • 19. Changes in tumor interstitial pressure induced by photodynamic therapy.
    Fingar VH, Wieman TJ, Doak KW.
    Photochem Photobiol; 1991 Jun 01; 53(6):763-8. PubMed ID: 1832229
    [Abstract] [Full Text] [Related]

  • 20. Increased efficacy of photodynamic therapy of R3230AC mammary adenocarcinoma by intratumoral injection of Photofrin II.
    Gibson SL, van der Meid KR, Murant RS, Hilf R.
    Br J Cancer; 1990 Apr 01; 61(4):553-7. PubMed ID: 2139578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.